弓形虫GRA4和SAG2基因重组BCG疫苗免疫保护性的比较研究

目的 比较弓形虫致密颗粒蛋白4（GRA4）基因和表面抗原2（SAG2）基因的重组卡介苗（BCG）对小鼠的免疫保护效果。 方法 108只SPF级雌性BALB/c小鼠随机分成6组：PBS组、BCG空白菌组、BCG?鄄空白载体组、BCG?鄄SAG2组、BCG-GRA4组和BCG-SAG2+GRA4组,每组18只。每鼠分别注射对应液体/疫苗100 μl,共2次,间隔2周。接种前尾静脉采血,接种后4、6、8周每组分别剖杀3只,取脾和眼眶血检测细胞因子、IgG与IgM抗体,T淋巴细胞亚群计数,淋巴细胞转化率等。末次免疫后3周,每组剩余小鼠分别腹腔接种RH株弓形虫速殖子50个进行攻击感染,观察各组小鼠存活时间。 结果 弓形虫SAG2和GRA4重组BCG疫苗均能诱导小鼠产生免疫应答。第4周时,BCG-GRA4+SAG2免疫组小鼠的CD3⁺CD4⁺/CD3⁺CD8⁺ 的比值最高,为14.06%±1.17%。第6周时,BCG-GRA4+SAG2免疫组小鼠的IgG抗体水平最高, 为0.18±0.02。第8周时,BCG-SAG2免疫组小鼠的IgM抗体水平最高,为0.82±0.05;弓形虫速殖子攻击后,BCG-SAG2组平均存活8.61 d,PBS对照组平均存活7.33 d,3个免疫组小鼠比其他3组的平均存活时间长1 d。 结论 弓形虫重组BCG疫苗具有一定的免疫保护性。

Study on Immuno-effect with GRA4 or SAG2 Gene Recombinant BCG Vaccine of Toxoplasma gondii

OBJECTIVE: To compare the immuno-protection induced by the recombinant BCG vaccine of Toxoplasma gondii GRA4 gene (rBCG-GRA4) and SAG2 gene (rBCG-SAG2) in BALB/c mice. METHODS: 108 SPF BALB/c mice were divided into 6 groups: PBS, BCG, rBCG, rBCG-GRA4, rBCG-SAG2 and rBCG-GRA4+SAG2, each with 18 mice. Each mouse was injected by 100 microl corresponding materials for 2 times. Blood was taken from tail vein before inoculation. 4,6 and 8 weeks after inoculation, spleen was moved and blood was taken from orbit vein of 3 mice from each group for the detection of cytokines, IgG and IgM antibodies, T lymphocyte subgroups and transformation efficiency. 3 weeks after the last inoculation, 9 mice from each group were challenged intraperitoneally with 50 tachyzoites of T. gondii RH strain and their survival time was observed. RESULTS: rBCG vaccine of T. gondii induced immune response. The value of CD3+ CD4+/CD3+CD8+ of group BCG-GRA4+SAG2 was the highest (14.06+/-1.17) in the 4th week; the IgG titer in the BCG-GRA4+SAG2 group was the highest (0.18+/-0.02) in the 6th week and the IgM titer in the BCG-SAG2 group was the highest (0.82+/-0.05) in the 8th week. The average survival time of the mice in BCG-SAG2 group was about 8.61 days after challenged with tachyzoites, and that of the PBS control group, 7.33 days. The average survival time in the 3 immunized groups was one day longer than that of the control. CONCLUSION: The rBCG vaccine of T. gondii shows certain immuno-protection in mice.